Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer | |
Lu, Jun-Yang; Xiao, Yi; Qiu, Hui-Zhong; Wu, Bin; Lin, Guo-Le; Xu, Lai; Zhang, Guan-Nan; Hu, Ke | |
2013 | |
卷号 | 108期号:4页码:213-219 |
关键词 | combined modality therapy rectal cancer pathologic response survival |
ISSN号 | 0022-4790 |
DOI | 10.1002/jso.23394 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6705626 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Lu, Jun-Yang,Xiao, Yi,Qiu, Hui-Zhong,et al. Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer[J],2013,108(4):213-219. |
APA | Lu, Jun-Yang.,Xiao, Yi.,Qiu, Hui-Zhong.,Wu, Bin.,Lin, Guo-Le.,...&Hu, Ke.(2013).Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.,108(4),213-219. |
MLA | Lu, Jun-Yang,et al."Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer".108.4(2013):213-219. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论